• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常血脂受试者中胆固醇合成与载脂蛋白B-100肝脏分泌之间的直接相关性。

Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects.

作者信息

Watts G F, Naoumova R, Cummings M H, Umpleby A M, Slavin B M, Sönksen P H, Thompson G R

机构信息

Department of Medicine, University of Western Australia, Perth.

出版信息

Metabolism. 1995 Aug;44(8):1052-7. doi: 10.1016/0026-0495(95)90104-3.

DOI:10.1016/0026-0495(95)90104-3
PMID:7637647
Abstract

The regulation of apolipoprotein B-100 (apo B) metabolism in man is not fully understood. In vitro studies suggest a key role for the hepatic availability of cholesterol substrate. We therefore examined whether there was a direct association between plasma mevalonic acid (MVA) concentration (an index of in vivo cholesterol synthesis) and hepatic secretion of very-low-density lipoprotein (VLDL) apo B in eight normolipidemic, healthy adult subjects. Hepatic secretion of VLDL apo B was estimated by endogenous labeling of apo B with an 8-hour primed, constant infusion of 1-13C-leucine. Isotopic enrichment of VLDL apo B was measured by gas chromatography-mass spectrometry (GCMS), from which the fractional secretion rate (FSR) was derived by a modified monoexponential function. Plasma concentration of MVA was measured by gas chromatography-electron-capture mass spectrometry in blood samples taken at 9 AM. The absolute secretion rate (ASR) of VLDL apo B (mean +/- SD) was 9.7 +/- 2.6 mg/kg/d, and MVA concentration was 5.0 +/- 2.5 ng/mL. There was a highly significant positive correlation between ASR of VLDL apoB and plasma MVA (r = .88, P = .004), which persisted after adjusting for apo E phenotype. The findings suggest that in vivo cholesterol synthesis is a determinant of hepatic secretion of apo B in normolipidemic subjects.

摘要

人类载脂蛋白B-100(apo B)代谢的调节机制尚未完全明确。体外研究表明胆固醇底物的肝脏可利用性起着关键作用。因此,我们在8名血脂正常的健康成年受试者中,研究了血浆甲羟戊酸(MVA)浓度(体内胆固醇合成的一个指标)与极低密度脂蛋白(VLDL)apo B的肝脏分泌之间是否存在直接关联。通过用1-13C-亮氨酸进行8小时的预充、持续输注对内源性apo B进行标记,来估计VLDL apo B的肝脏分泌。通过气相色谱-质谱联用仪(GCMS)测量VLDL apo B的同位素富集情况,并通过修正的单指数函数得出分数分泌率(FSR)。在上午9点采集的血样中,通过气相色谱-电子捕获质谱法测量血浆MVA浓度。VLDL apo B的绝对分泌率(ASR)(均值±标准差)为9.7±2.6 mg/kg/d,MVA浓度为5.0±2.5 ng/mL。VLDL apoB的ASR与血浆MVA之间存在高度显著的正相关(r = 0.88,P = 0.004),在对apo E表型进行校正后该相关性依然存在。这些发现表明,在血脂正常的受试者中,体内胆固醇合成是apo B肝脏分泌的一个决定因素。

相似文献

1
Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects.正常血脂受试者中胆固醇合成与载脂蛋白B-100肝脏分泌之间的直接相关性。
Metabolism. 1995 Aug;44(8):1052-7. doi: 10.1016/0026-0495(95)90104-3.
2
Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man.人体中极低密度脂蛋白载脂蛋白B-100的肝脏分泌与血浆甲羟戊酸和羊毛甾醇浓度之间的直接关联。
Atherosclerosis. 1997 Nov;135(1):83-91. doi: 10.1016/s0021-9150(97)00153-6.
3
Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.杂合子家族性高胆固醇血症患者肝脏极低密度脂蛋白载脂蛋白B-100分泌增加:一项稳定同位素研究。
Atherosclerosis. 1995 Feb;113(1):79-89. doi: 10.1016/0021-9150(94)05430-q.
4
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease.胆固醇酯贮积病中极低密度脂蛋白载脂蛋白B-100的肝脏分泌增加。
Clin Chem. 1995 Jan;41(1):111-4.
5
Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.采用稳定同位素技术对内脏性肥胖男性极低密度脂蛋白载脂蛋白B-100的肝脏分泌情况进行研究。
Int J Obes Relat Metab Disord. 1998 May;22(5):414-23. doi: 10.1038/sj.ijo.0800602.
6
Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.在血脂正常的受试者中,抑制胆固醇生成可减少载脂蛋白B-100的肝脏分泌。
Am J Physiol. 1997 Sep;273(3 Pt 1):E462-70. doi: 10.1152/ajpendo.1997.273.3.E462.
7
Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.辛伐他汀可降低杂合子家族性高胆固醇血症患者极低密度脂蛋白载脂蛋白B-100的肝脏分泌:病理生理学及治疗意义
Eur J Clin Invest. 1995 Aug;25(8):559-67. doi: 10.1111/j.1365-2362.1995.tb01746.x.
8
Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism.生长激素治疗对成年垂体功能减退症患者极低密度脂蛋白载脂蛋白B100周转率的影响。
Metabolism. 2000 May;49(5):563-6. doi: 10.1016/s0026-0495(00)80028-1.
9
Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.载脂蛋白B信号肽和载脂蛋白E基因型作为肥胖男性极低密度脂蛋白载脂蛋白B肝脏分泌的决定因素。
J Lipid Res. 1998 Sep;39(9):1752-8.
10
Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.急性高胰岛素血症可降低非胰岛素依赖型糖尿病患者肝脏极低密度脂蛋白载脂蛋白B-100的分泌。
Diabetes. 1995 Sep;44(9):1059-65. doi: 10.2337/diab.44.9.1059.

引用本文的文献

1
Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.使用稳定同位素示踪剂研究载脂蛋白周转率:正确的分析方法是对富集情况进行建模。
J Lipid Res. 2006 Dec;47(12):2738-53. doi: 10.1194/jlr.M600302-JLR200. Epub 2006 Sep 1.
2
Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.使用环糊精在HepG2细胞中递送脂质并调节载脂蛋白B-100的产生。
Lipids. 1997 Aug;32(8):811-23. doi: 10.1007/s11745-997-0104-2.
3
Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias.
阿托伐他汀。其在高脂血症管理中的药理学及治疗潜力综述。
Drugs. 1997 May;53(5):828-47. doi: 10.2165/00003495-199753050-00011.